¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"proton acceptor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor
    ¼ö¿ëü, ¹Þ°³
  • deshielded proton
    ¹ÌÂ÷Æó¾ç¼ºÀÚ
  • free water proton
    ÀÚÀ¯¹°¾ç¼ºÀÚ, ÀÚÀ¯¼öºÐ¾ç¼ºÀÚ
  • high intensity proton flow
    °í°­µµ¾çÀÚÈ帧, °í°­µµ¾çÀÚÀ¯µ¿
  • nonsaturated proton
    ºñÆ÷È­¾ç¼ºÀÚ
  • proton
    ¾ç¼ºÀÚ
  • proton density contrast
    ¾ç¼ºÀڹеµ´ëÁ¶
  • proton density weighted image
    ¾ç¼ºÀڹеµ°­Á¶¿µ»ó
  • proton flow
    ¾ç¼ºÀÚÈ帧, ¾ç¼ºÀÚÀ¯µ¿
  • proton pump
    ¾ç¼ºÀÚÆßÇÁ
  • proton relaxation
    ¾ç¼ºÀÚÀÌ¿Ï
  • proton shift
    ¾ç¼ºÀÚÀ̵¿
  • recoil proton
    ¹Ýµ¿¾ç¼ºÀÚ
  • replaceable proton
    ´ëü¾ç¼ºÀÚ
  • shielding proton
    Â÷Æó¾ç¼ºÀÚ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proton density
    ¾çÀڹеµ
  • proton density weighted image
    ¾çÀڹеµ°­Á¶¿µ»ó
  • proton
    ¾ç¼ºÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor
    ¼ö¿ëü, ¹Þ°³
  • acceptor site
    ¼ö¿ëºÎÀ§
  • proton density contrast
    ¾çÀڹеµ´ëÁ¶
  • deshielded proton
    ¹ÌÂ÷Æó¾ç¼ºÀÚ
  • proton density
    ¾çÀڹеµ
  • proton flow deficit
    ¾çÀÚÈ帧°áÇÌ
  • magnetic susceptibility proton relaxation enhancement
    ÀÚ±âÈ­À²¾ç¼ºÀÚÀÌ¿ÏÁõ°­
  • free water proton
    ÀÚÀ¯¹°¾ç¼ºÀÚ
  • high intensity proton flow
    °í°­µµ¾çÀÚÈ帧, °í°­µµ¾çÀÚÀ¯µ¿
  • proton flow
    ¾çÀÚÈ帧, ¾çÀÚÀ¯µ¿
  • proton density weighted image
    ¾çÀڹеµ°­Á¶¿µ»ó
  • nonsaturated proton
    ºñÆ÷È­¾çÀÚ
  • proton
    ¾ç¼ºÀÚ
  • proton relaxation
    ¾çÀÚÇ®¸², ¾çÀÚÀÌ¿Ï
  • proton shift
    ¾ç¼ºÀÚÀ̵¿
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor
    ¼ö¿ëü, ¼ö·Éü äÅÃÀÚ.
  • acceptor site
    ¼ö¿ëºÎÀ§
  • hydrogen acceptor
    ¼ö¼Ò¼ö¿ëü.
  • High intensity proton flow
    °í°­µµ ¾çÀÚ À¯µ¿
  • free water proton
    ÀÚÀ¯ ¼öºÐ ¾ç¼ºÀÚ
  • proton
    ¾ç¼ºÀÚ(åÕàõí­).
  • proton
    ¾ç¼ºÀÚ
  • proton (spin) density
    ¾çÀÚ ¹Ðµµ
  • proton beam therapy
    ¾çÀÚ¼±Ä¡·á
  • proton density contrast
    ¾çÀÚ ¹Ðµµ ´ëÁ¶
  • proton density weighted image
    ¾çÀÚ ¹Ðµµ °­Á¶ ¿µ»ó
  • recoil proton
    ¹Ýµµ¾çÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • proton proton dipole dipole interaction
    ¾çÀÚ ¾çÀÚ ½Ö±ØÀÚ ½Ö±ØÀÚ »óÈ£¹ÝÀÀ
  • acceptor
    ¼ö¿ëü, ¼ö·Éü äÅÃÀÚ.
  • acceptor site
    ¼ö¿ëºÎÀ§
  • hydrogen acceptor
    ¼ö¼Ò¼ö¿ëü.
  • deshielded proton
    ¹ÌÂ÷Æó ¾ç¼ºÀÚ
  • free water proton
    ÀÚÀ¯ ¼öºÐ ¾ç¼ºÀÚ
  • low intensity void in proton flow
    ¾ç¼ºÀÚ È帧ÀÇ Àú°­µµ ¼Ò½Ç
  • nonsaturated proton
    ºñÆ÷È­ ¾çÀÚ
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º ¾çÀÚ ÀÌ¿Ï Áõ°­
  • proton
    ¾ç¼ºÀÚ(åÕàõí­).
  • proton
    ¾ç¼ºÀÚ
  • proton (spin) density
    ¾çÀÚ ¹Ðµµ
  • proton MR spectroscopy
  • proton beam therapy
    ¾çÀÚ¼±Ä¡·á
  • proton density contrast
    ¾çÀÚ ¹Ðµµ ´ëÁ¶
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor RNA
    ¼ö¿ë(â¥é»)RNA
  • acceptor control
    ¼ö¿ëü Á¦¾î (â¥é»ô÷ ð¤åÙ)
  • acceptor site
    ¼ö¿ëºÎÀ§ (â¥é»Ý»êÈ)
  • acceptor-control ratio
    ¼ö¿ëü Á¦¾îÀ² (â¥é»ô÷ ð¤åÙëÒ)
  • electron acceptor
    ÀüÀÚ ¼ö³³Ã¼(ï³í­ áôÒ¡ô÷)
  • low-energy phophate acceptor
    Àú(î¸)¿¡³ÊÁö Àλê¼ö³³Ã¼(×òß«áôÒ¡ô÷)
  • phosphate acceptor peptide
    Àλê¼ö¿ë(×òß«áôé») ÆéŸÀ̵å
  • proton
    ¾ç¼ºÀÚ(åÕàõí­)
  • proton abstraction
    ¾ç¼ºÀÚ ÃßÃâ(õÎõó)
  • proton affinity
    ¾ç¼ºÀÚ Ä£È­µµ(öÑûúÓø)
  • proton gradient
    ¾ç¼ºÀÚ ±â¿ï±â
  • proton magnetic reasonance
    ¾ç¼ºÀÚ ÀÚ±â°ø¸í(åÕàõí­àõí¸Ñ¨ÍìÙ°)
  • proton motive force
    ¾ç¼ºÀÚ ±¸µ¿·Â(åÕàõí­àõÏÌÔÑÕô)
  • proton-motive hypothesis
    ¾ç¼ºÀÚ ±¸µ¿¼³(åÕàõí­àõÏËÔÑàã)
  • proton pump
    ¾ç¼ºÀÚ(åÕàõí­) ÆßÇÁ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor
    ¼ö¿ëü
  • proton proton dipole dipole interaction
    ¾çÀÚ¾çÀÚ½Ö±ØÀÚ½Ö±ØÀÚ»óÈ£¹ÝÀÀ
  • deshielded proton
    ¹ÌÂ÷Æó¾ç¼ºÀÚ
  • free water proton
    ÀÚÀ¯¼öºÐ¾ç¼ºÀÚ
  • gradient echo technique magnetic susceptibility proton relaxation enhancement
    °æ»ç¿¡ÄÚ¹ý±âÈ­À²¼ºÀÚÀÌ¿ÏÁõ°­
  • high intensity proton flow
    °í°­µµ¾çÀÚÀ¯µ¿
  • lipid bound proton
    Áö¹æ°áÇվ缺ÀÚ
  • low intensity void in proton flow
    ¾ç¼ºÀÚÈ帧ÀÇ Àú°­µµ¼Ò½Ç
  • nonsaturated proton
    ºñÆ÷È­¾çÀÚ
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º¾çÀÚÀÌ¿ÏÁõ°­
  • proton
    ¾ç¼ºÀÚ
  • proton (spin) density
    ¾çÀڹеµ
  • proton density contrast
    ¾çÀڹеµ´ëÁ¶
  • proton density weighted image
    ¾çÀڹеµ°­Á¶¿µ»ó
  • proton density weighting
    ¾çÀÚ°­Á¶
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
D-A donor-acceptor
EDA electrodermal activity; electrodermal audiometry; electrolyte-deficient agar; electron donor accepto...
MAP malignant atrophic papulosis; mandibular angle plane; maturation-activated protein; maximal aerobic ...
N(H) proton density
PIXE particle-induced x-ray emission; proton-induced x-ray emission
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
A D)-acceptor
1H NMR High resolution proton nuclear magnetic resonance
PIXE Proton Induced X-ray Emission
PPI Proton Pump Inhibitor
PD Proton density
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • proton proton dipole dipole interaction
    ¾çÀÚ ¾çÀÚ ½Ö±ØÀÚ ½Ö±ØÀÚ »óÈ£ ¹ÝÀÀ
  • hydrogen acceptor
    ¼ö¼Ò ¼ö¿ëü
    ½Åü Á¶Á÷ Áß¿¡¼­ Çø±âÀûÀ¸·Î ÀϾ´Â »êÈ­ ȯ¿ø ¹ÝÀÀ¿¡¼­ ȯ¿øµÇ´Â ¹°Áú.
  • high intensity proton flow
    °í°­µµ ¾çÀÚÀ¯µ¿
  • nonsaturated proton
    ºñÆ÷È­ ¾çÀÚ
  • paramagnetic proton relaxation enhancement
    »óÀÚ¼º ¾çÀÚ ÀÌ¿Ï Áõ°­
  • proton density contrast
    ¾çÀÚ ¹Ðµµ ´ëÁ¶
  • proton density weighting
    ¾çÀÚ °­Á¶
  • proton flow
    ¾çÀÚ À¯µ¿
  • proton flow deficit
    ¾çÀÚ À¯µ¿ °áÇÌ
  • proton relaxation
    ¾çÀÚ ÀÌ¿Ï
  • proton spin density
    ¾çÀÚ ¹Ðµµ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
proton acceptor <chemistry> A base, an anionic substance that acceptsa proton during an acid-basereaction.
(09 Oct 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
membrane-bound proton-translocating PPi synthase <enzyme> From rhodospirillum rubrum; functions as an alternative coupling factor; n,n'-dicyclohexylcarbodiimide-sensitive; catalyses the phosphorylation of pi to ppi, the hydrolysis of ppi and the concomitant translocation of proton across the plasma membrane
Registry number: EC 3.6.1.-
Synonym: h(+)-ppi synthase
(26 Jun 1999)
proton <physics> An elementary atomic particle with a positive charge and a mass of about 1 amu.
(09 Oct 1997)
proton ATPase <enzyme> An ion pump that actively transports hydrogen ions across lipid bilayers in exchange for ATP.
Major groups are the F-type ATPases, that run in reverse to synthesise ATP in bacterial, mitochondrial and chloroplast membranes (ATP synthase) and the V-type ATPases found in intracellular vesicles with an acidic lumen and on certain epithelial cells (e.g. Kidney intercalated cells). Gastric H/K ATPase is a proton ATPase.
(18 Nov 1997)
proton donor <chemistry> An acid, a susbstance that donates protons in an acid-base reduction reaction.
(10 Jan 1998)
proton-motive force Energy that is generated by the transfer of protons or electrons across an energy-transducing membrane and that can be used for chemical, osmotic, or mechanical work. Proton-motive force can be generated by a variety of phenomena including the operation of an electron transport chain, illumination of a purple membrane, and the hydrolysis of ATP by a proton atpase.
(12 Dec 1998)
proton pump Integral membrane proteins that transport protons across a membrane against a concentration gradient. This transport is driven by hydrolysis of ATP by hydrogen-transporting ATP synthase.
(12 Dec 1998)
proton pump inhibitor <pharmacology> A group of anti-ulcer medications which work by binding to H+/K+ ATPase, an enzyme which is found on the secretory surface of parietal cells. It thereby inhibits the final transport of hydrogen ions (via exchange with potasium) into the gastric lumen.
Examples of proton pump inhibitors include omeprazole and lansoprazole.
(27 Sep 1997)
acceptor A compound that will take up a chemical group (e.g., an amine group, a methyl group, a carbamoyl group) from another compound (the donor); under the action of alanine transaminase, l-glutamic acid is an amine donor while pyruvic acid is an amine acceptor.
Origin: L. Ac-cipio, pp. -ceptus, to accept
(05 Mar 2000)
acceptor control <biochemistry> The regulation of the respiration rate, governed by ADP's ability to be a phosphate group acceptor.
(06 May 1997)
acceptor RNA rNA
acceptor site The ribosomal binding site for the aminoacyl-tRNA during protein synthesis.
(05 Mar 2000)
acceptor splicing site Boundary between the right end of an intron and the left end of the adjacent exon.
Synonym: acceptor splicing site.
(05 Mar 2000)
alcohol dehydrogenase (acceptor) An oxidoreductase that reversibly converts primary alcohols to aldehydes with an H acceptor other than NADP+.
(05 Mar 2000)
phenylglyoxylate - acceptor oxidoreductase <enzyme> Requires coenzyme a; converts phenylglyoxylate to benzoyl-CoA with release of co2
Registry number: EC 1.2.99.-
Synonym: phenylglyoxylate oxidoreductase (acylating)
(26 Jun 1999)
hydrogen acceptor A molecule that, in conjunction with a tissue enzyme system, carries hydrogen from one metabolite (oxidant) to another (reductant) or to molecular oxygen to form H2O.
Synonym: hydrogen acceptor.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acceptor
    ¾îÀ½ ÀμöÀÎ
  • proton
    ¾çÀÚ
  • proton
    ÇÁ·ÎÅæ;¾çÀÚ. protonic a.
  • proton decay
    ¾çÀÚ ºØ±«
  • proton synchrotron
    ¾çÀÚ °¡¼Ó ÀåÄ¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á